Shares of Immunovant, Inc. (NASDAQ:IMVT – Get Rating) have earned a consensus rating of “Hold” from the seven analysts that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and three have assigned a buy recommendation to the company. The […]
Innate Pharma (OTCMKTS:IPHYF – Get Rating) and Immunovant (NASDAQ:IMVT – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership and profitability. Risk & Volatility Innate Pharma has a beta of 0.67, […]